verapamil and 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

verapamil has been researched along with 1-phenyl-2-decanoylamino-3-morpholino-1-propanol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Di Bartolomeo, S; Luly, P; Spinedi, A	1

Other Studies

1 other study(ies) available for verapamil and 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

Article	Year
P-Glycoprotein is not a key target for the chemosensitizing effect of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol in HepG2 cells exposed to doxorubicin. Drug metabolism letters, 2010, Volume: 4, Issue:1 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Morpholines; Verapamil	2010

Article

Year

P-Glycoprotein is not a key target for the chemosensitizing effect of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol in HepG2 cells exposed to doxorubicin.

Drug metabolism letters, 2010, Volume: 4, Issue:1

Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Morpholines; Verapamil

2010